When I transitioned from my postdoc to my first industry role at a biotech company, I made a critical mistake. I accepted the first offer without negotiating. Not because I didn’t know I could negotiate, but because I was so relieved to have an offer at all that the thought of asking for more felt greedy. Six months in, when I learned that a peer hired around the same time was making roughly 12% more than me, I realized what that “politeness” had cost me. Over a three-year tenure, that was nearly $70,000 left on the table.
I later learned that this pattern is incredibly common among scientists transitioning from academia to industry. We’re trained to be grateful for opportunities. We’re conditioned to expect that authority figures (hiring managers, grant reviewers, hiring committees) know what’s fair. Negotiating feels confrontational, especially coming from a culture where the PI sets the stipend and you don’t question it. The good news: salary negotiation in biotech and pharma is not only expected, it’s standard. Not negotiating is actually a red flag to experienced hiring managers. It suggests either you don’t know your value or you don’t advocate for yourself. In a field that values independence, that’s not the signal you want to send.
This guide will walk you through how to research market rates, understand what you’re actually being offered, and negotiate effectively without damaging the relationship or losing the offer.
Know Your Market Value
The first step is research. You cannot negotiate effectively without knowing what people in similar roles actually earn. The challenge is that biotech and pharma salaries are not always transparent, and ranges vary significantly by company size, geography, stage, and specific role.
Start with Levels.fyi, which aggregates compensation data across tech and biotech companies. While it’s more heavily weighted toward software roles, it includes biotech and pharma positions, and the data is usually recent and specific to company. You can filter by company, level, and location, and you’ll see distributions of base salary, equity, and bonus for each role.
Glassdoor is another standard resource, though the data quality varies by company and role specificity. Filter by company and job title, and look for reviews from people in roles similar to yours. The salary reviews are usually within the last 1-2 years.
LinkedIn Salary (available in the US) provides crowd-sourced salary data by company, title, and location. It’s less detailed than Levels.fyi but it’s updated regularly.
For biotech-specific data, browse job postings on BioSpace and note the salary ranges that public companies are advertising. This gives you a floor for what companies are willing to pay for roles they’re actively hiring for.
Finally, talk to people. Reach out to peers who have recently accepted industry roles, to former colleagues who made the transition, or to alumni from your PhD program now in industry. Frame it as information gathering, not as asking for their personal salary: “I’m exploring industry roles, and I’m trying to understand market rates for Associate Scientist positions at Series B biotech companies on the West Coast. Have you seen recent offers in that space?” Most people will give you useful information. Many will also tell you they negotiated and what they negotiated for.
Based on research across these sources, here are approximate ballpark ranges for common entry-level industry roles for PhD scientists. These are estimated ranges for 2025, vary significantly by company stage and location, and should be treated as illustrative starting points, not guarantees:
- Associate Scientist (early career, 0-3 years post-PhD): $80,000 to $120,000 base salary
- Senior Associate Scientist (3-6 years post-PhD or equivalent): $110,000 to $160,000 base salary
- Scientist I (independent contributor role, more seniority): $130,000 to $180,000 base salary
- Scientist II / Senior Scientist: $160,000 to $230,000 base salary
These ranges are wider at larger, better-funded companies and narrower at early-stage startups. A Series A biotech in the Midwest may offer differently than a late-stage company in the San Francisco Bay Area. Public companies often pay at the higher end; early-stage startups at the lower end. But if you’re being offered $75,000 as a postdoc-trained PhD for an Associate Scientist role at a Series B company, you know you have a data point to negotiate from.
The Structure of a Biotech and Pharma Offer
When a hiring manager verbally tells you they’re “offering $110,000,” that is not your full compensation. This is critical to understand because it’s where many scientists get confused, and where negotiation happens.
Total compensation typically includes:
Base Salary: The annual salary. This is taxed as regular income. In biotech and pharma, this is often 60-70% of total compensation.
Equity: At public companies, this is usually Restricted Stock Units (RSUs), vesting over four years. At private companies (especially pre-IPO startups), this is usually stock options with a vesting cliff (usually one year before you get any equity, then monthly vesting over four years). The value of equity is uncertain (startup equity might be worthless if the company fails or underperforms), but at more mature companies it can represent 20-40% of total compensation.
Annual Bonus: Usually 10-20% of base salary. This is performance-based and varies by company and individual performance, but it’s expected.
Sign-on Bonus: A one-time payment, usually given in your first month. For people transitioning from academia or from another company, this can be substantial, often $10,000-$30,000 or more. It’s specifically meant to offset relocation costs or to make up for equity you’re leaving behind at a previous company.
Benefits: Health insurance (employer usually covers 60-80% of premiums), 401(k) match (often 3-6%), dental, vision, life insurance, disability insurance. Some companies also offer mental health benefits, wellness stipends, and professional development budgets.
Paid Time Off: Varies widely; biotech companies often offer 20-25 days of PTO plus 7-10 paid holidays, which is more generous than academic postdocs but varies.
When you’re evaluating an offer, add up the estimated total value, not just the base salary. A $115,000 base with 0.5% equity in a pre-IPO company (which could be worth a lot if they exit) plus a $20,000 sign-on bonus is quite different from a $115,000 base with no equity at a stable late-stage company.
Timing: When to Negotiate
Timing is critical. You negotiate after you receive a written offer, not during interviews. Early in the interview process, if asked “What salary are you looking for?” you should deflect with something like: “I’m more interested in finding the right role and team fit. I’m open to compensation that’s competitive for the position and my experience. What range did you have in mind?”
If they push, you can give a range based on your research: “Based on my research into similar roles at companies of your stage and size, I’d expect something in the range of $110,000 to $135,000. I’m flexible within that range depending on the full package.” This anchors you without locking you in.
Once you have a written offer, ask for time to consider it. You can always say: “Thank you for the offer. I’d like to take a few business days to review it thoughtfully. Can we touch base on [specific date 3-5 days away]?” This is completely normal and expected. No hiring manager will be upset by this request. In fact, it demonstrates that you take decisions seriously.
Use those 3-5 days to do your research, compare the offer to market rates, and decide if and how you want to counter.
The Negotiation Conversation
You have two options: negotiate via email or phone/video call. Phone or video is almost always better. It’s harder to misinterpret tone, you can have a real conversation, and you can respond more dynamically to what the hiring manager says.
Call them during business hours, confirm they have a few minutes, and then deliver your counter-offer calmly and professionally.
Script template:
“Thank you so much for the offer. I’m genuinely excited about the role and the team. I’ve had a chance to research market rates for this position, and based on my analysis of similar roles at peer companies and my specific experience with [relevant technical skills], I was expecting the base salary to be closer to $[number]. Is there flexibility there?”
The number you choose should be:
- Based on data you’ve gathered (not random)
- Within the range you researched, probably at the higher end
- Reasonable enough that you believe they can meet it
- Typically 10-15% higher than their opening offer, unless your research strongly suggests they’re significantly below market
For example: if they offer $100,000 and your research suggests $110,000-$130,000 for your role and experience, asking for $120,000 is reasonable and data-driven.
What happens next varies:
If they say “Yes, we can do $120,000,” you’ve succeeded. Confirm in writing.
If they say “That’s higher than we budgeted. We can do $110,000,” you have choices: accept, counter again (“Is there flexibility on sign-on bonus or equity to bridge that gap?”), or ask about other elements (see the next section).
If they say “That’s not possible. Our budget is firm at $100,000,” you need to decide: Is the offer acceptable at $100,000? If you have other offers, you can say so diplomatically: “I appreciate that. I do have another offer at a higher range. Is there anything else in the package we could adjust?” If you don’t, you can ask about other elements.
If they seem frustrated or push back hard, don’t escalate. Recognize that you may have hit their limit. You can say: “I understand. Let me think about this and I’ll get back to you.” Then decide privately whether to accept or walk away.
Negotiating Beyond Base Salary
If base salary is fixed, other elements are often negotiable, especially in smaller companies with more flexibility.
Sign-on Bonus: This is the easiest to move. If they won’t budge on salary, asking for a higher sign-on bonus is a reasonable pivot: “If the base is fixed at $100,000, could we discuss a sign-on bonus to offset moving costs? I was thinking $15,000-$20,000.” At many companies, this comes from a different budget than salary, so they may have more flexibility.
Equity: At public companies, RSU grants are often based on level and can be difficult to change. At private companies, option grants are more flexible. If they won’t move on salary, you can ask: “Could the option grant be increased to reflect the market rate I expected?” This doesn’t cost them cash.
Title: Titles matter for your career. If the offered salary is lower than you expected, a more senior title (Scientist I instead of Associate Scientist) might be worth it, since titles affect future earning potential and opportunities. “I understand the budget constraint on salary. Would you be open to having me join as a Scientist I instead of Associate Scientist?” This can also come with a bump in future equity or bonus potential.
Remote Work Flexibility: Especially relevant if you’re moving for the role. “Is there flexibility to work remotely part-time?” can add value beyond cash if you value flexibility.
Professional Development Budget: “Does the team have a professional development budget I could use for courses, conferences, or certifications?” This costs the company little and benefits you over time.
Extra PTO: “Is there flexibility to have 3 additional days of PTO beyond the standard offer?” Larger companies are less flexible, but smaller ones often are.
Relocation Assistance: If you’re moving, ask explicitly: “What relocation assistance is included in the offer?” Many companies have a budget for this but don’t mention it unless asked.
What to Negotiate, and When to Stop
Negotiation is a conversation, not a battle. After you make a counter-offer, the hiring manager will respond. If they move (increase salary, add sign-on bonus, increase equity), you’re in a real negotiation. You can counter once more, but after that, you need to decide: accept or decline.
Signs that you’ve reached their limit:
- They’ve said the same number twice
- They’re suggesting they need to go to their CFO or budget holder and they’ll “see what they can do,” but nothing changes
- They’re getting visibly frustrated
- They’ve offered to move on equity or sign-on, but you’re still asking for more base salary
At that point, make a decision and commit. If the offer is acceptable, accept and move forward. If it’s not, decline respectfully. You can say: “I appreciate your willingness to work with me on this. Unfortunately, I don’t think we can make the numbers work. I’m going to pursue another opportunity, but thank you for the time and I hope our paths cross in the future.”
This is hard. It feels like you’re walking away from a sure thing. But if an offer is truly below your market value and the company won’t meet you partway, it’s better to know that now than to build resentment over time.
Common Mistakes
Anchoring too low. If you ask for $105,000 when you researched $120,000-$135,000, you’ve anchored them to a lower number. They’re unlikely to counter offer significantly higher. Lead with a number based on your research.
Accepting the first offer without pause. Even if you’re delighted, pause. Ask for time. Negotiate. It signals self-respect and cost you nothing if they say no.
Negotiating via email when a conversation is possible. Email is ambiguous and slower. Call them.
Being aggressive or emotional. “That’s insulting” or “I expected much higher” puts them on the defensive. Stick to data: “Based on market research, I expected…” is professional; “Your offer is too low” is confrontational.
Negotiating every single element. Pick 1-2 things to negotiate. Going back on base, then equity, then sign-on, then PTO exhausts their goodwill. Choose the 1-2 elements that matter most to you and focus there.
Revealing other offers as a threat. “I have another offer at $130,000” can backfire if they’re not willing to match. Instead, use it as context: “I do have another offer at a higher range. I’m more interested in your company, but I need the compensation to reflect that priority.”
Bottom Line
You earn a significant portion of your lifetime income during your career transition from academia to industry. A $15,000 difference in starting salary, compounded over 10 years with raises and promotions, can easily become $200,000+ in difference. Negotiation is not greedy or confrontational; it’s standard business practice and expected in biotech and pharma.
Here’s what to do now: Research market rates for your target role using Levels.fyi, Glassdoor, and LinkedIn Salary. Talk to 2-3 people in industry roles similar to the one you’re pursuing and ask them what they learned about market rates. When you get an offer, ask for 3-5 days to review it. Counter with a number backed by data, be prepared to negotiate other elements if base salary is fixed, and know when to stop negotiating and make a final decision. You have more leverage than you think, and companies expect you to use it.
One book worth reading before any negotiation: Never Split the Difference by Chris Voss. It’s written by a former FBI hostage negotiator, and while the scenarios are extreme, the underlying techniques — mirroring, labeling, calibrated questions — translate directly to salary conversations. The chapter on anchoring alone is worth the read.